In the past decade, growth of the life science industry within the US, Canada and UK & Ireland has slowed downed but they are still in the top 10 Global Pharmaceutical Markets. Support for the discovery, development, and commercialization of medical innovations will attract investment and could maintain the dominant positions these economies have in this sector and provide more effective treatments for patients.
We have had a strong presence in European countries, the UK included; however, Trifermed has also ventured overseas to establish a strong network in Canada. We have contacts across many fields, namely by being members of various groups and associations, and by attending congresses. With the same successful strategy we are building up a stable presence in the USA. Stephanie achieved a BSc in Biological Sciences with Pharmacology Honours from the University of Edinburgh and has finished an MSc in Specialized Economic Analysis from the Universitad Pompeu Fabra and Universitad Autonoma de Barcelona. She began working for Trifermed as a Market Researcher and focused her time supporting the Scandinavian, UK and Canadian markets. As she has worked in France and the UK, her knowledge of both languages helps her with the management of her Business Unit in the UK, US and Canadian markets.
In her free time, she likes to keep active so she regularly goes on runs, walks or hikes. She is part of a local hockey team and plays on a regular basis.